Activation	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
interleukin	B-protein
2	I-protein
in	O
human	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
.	O

We	O
report	O
here	O
that	O
interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
acts	O
on	O
human	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
by	O
enhancing	O
binding	O
activity	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
to	O
its	O
consensus	O
sequence	O
in	O
the	O
5	O
'	O
regulatory	O
enhancer	O
region	O
of	O
the	O
IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
chain	I-DNA
(	O
p55	B-protein
)	O
.	O

Similarly	O
,	O
IL-2	B-protein
activates	O
NF-kappa	B-protein
B	I-protein
in	O
the	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
U	I-cell_line
937	I-cell_line
,	O
but	O
not	O
in	O
resting	B-cell_type
human	I-cell_type
T-cells	I-cell_type
.	O

This	O
effect	O
is	O
detectable	O
within	O
15	O
min	O
and	O
peaks	O
1	O
h	O
after	O
exposure	O
to	O
IL-2	B-protein
.	O

Enhanced	O
NF-kappa	B-protein
B	I-protein
binding	O
activity	O
is	O
followed	O
by	O
functional	O
activation	O
in	O
that	O
inducibility	O
of	O
the	O
IL-2	B-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
is	O
mediated	O
by	O
enhanced	O
NF-kappa	B-protein
B	I-protein
binding	O
and	O
that	O
a	O
heterologous	O
promoter	O
containing	O
the	O
NF-kappa	B-DNA
B	I-DNA
consensus	I-DNA
sequence	I-DNA
(	O
-291	B-DNA
to	I-DNA
-245	I-DNA
)	O
of	O
the	O
IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
chain	I-DNA
gene	I-DNA
is	O
activated	O
.	O

In	O
addition	O
,	O
IL-2	B-protein
is	O
capable	O
of	O
increasing	O
transcript	O
levels	O
of	O
the	O
p50	B-protein
gene	O
coding	O
for	O
the	O
p50	B-protein
subunit	I-protein
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	O
factor	O
,	O
whereas	O
mRNA	O
levels	O
of	O
the	O
p65	B-protein
NF-kappa	B-DNA
B	I-DNA
gene	I-DNA
remained	O
unchanged	O
.	O

Vol	NULL
.	NULL

3	NULL
,	NULL
421-427	NULL
,	NULL
July	NULL
1992	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
421	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
Interleukin	NULL
2	NULL
in	NULL
Human	NULL
Blood	NULL
Monocytes	NULL
'	NULL
M.	NULL
A.	NULL
Brach	NULL
,	NULL
H-J	NULL
.	NULL

Gruss	NULL
,	NULL
D.	NULL
Riedel	NULL
,	NULL
R.	NULL
Mertelsmann	NULL
,	NULL
and	NULL
F.	NULL
Herrmann	NULL
``	NULL
Departments	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
Medical	NULL
Center	NULL
,	NULL
Hugstetter	NULL
Strasse	NULL
55	NULL
,	NULL
D-7800	NULL
Freiburg	NULL
,	NULL
Germany	NULL
Abstract	NULL
We	NULL
report	NULL
here	NULL
that	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
acts	NULL
on	NULL
human	NULL
blood	NULL
monocytes	NULL
by	NULL
enhancing	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
its	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
5	NULL
regulatory	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
p55	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
IL-2	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
U	NULL
937	NULL
,	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
human	NULL
T-cells	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
detectable	NULL
within	NULL
15	NULL
min	NULL
and	NULL
peaks	NULL
1	NULL
h	NULL
after	NULL
exposure	NULL
to	NULL
IL-2	NULL
.	NULL

Enhanced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
followed	NULL
by	NULL
functional	NULL
activation	NULL
in	NULL
that	NULL
inducibility	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
is	NULL
mediated	NULL
by	NULL
enhanced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
and	NULL
that	NULL
a	NULL
heterologous	NULL
promoter	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
(	NULL
-291	NULL
to	NULL
-245	NULL
)	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
gene	NULL
is	NULL
activated	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-2	NULL
is	NULL
capable	NULL
of	NULL
increasing	NULL
transcript	NULL
levels	NULL
of	NULL
the	NULL
p50	NULL
gene	NULL
coding	NULL
for	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
,	NULL
whereas	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
p65	NULL
NF-	NULL
«	NULL
B	NULL
gene	NULL
remained	NULL
unchanged	NULL
.	NULL

Introduction	NULL
The	NULL
high	NULL
affinity	NULL
IL-2R®	NULL
consists	NULL
of	NULL
a	NULL
and	NULL
8	NULL
chains	NULL
,	NULL
but	NULL
only	NULL
the	NULL
8	NULL
chain	NULL
participates	NULL
in	NULL
signaling	NULL
of	NULL
IL-2	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
IL-2R	NULL
8	NULL
chain	NULL
have	NULL
recently	NULL
identified	NULL
a	NULL
small	NULL
region	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
sufficient	NULL
for	NULL
signal	NULL
transduction	NULL
.	NULL

This	NULL
region	NULL
has	NULL
also	NULL
been	NULL
postulated	NULL
to	NULL
represent	NULL
an	NULL
active	NULL
site	NULL
required	NULL
for	NULL
association	NULL
with	NULL
a	NULL
second	NULL
messenger	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
cascade	NULL
and	NULL
to	NULL
potentially	NULL
act	NULL
via	NULL
a	NULL
phosphorylation	NULL
signal	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
lymphocytes	NULL
,	NULL
such	NULL
a	NULL
second	NULL
messenger	NULL
molecule	NULL
interacting	NULL
with	NULL
the	NULL
J	NULL
chain	NULL
was	NULL
recently	NULL
identified	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Human	NULL
blood	NULL
monocytes	NULL
constitutively	NULL
express	NULL
the	NULL
IL-2R	NULL
8	NULL
chain	NULL
(	NULL
p75	NULL
)	NULL
(	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
(	NULL
p55	NULL
)	NULL
by	NULL
human	NULL
blood	NULL
monocytes	NULL
is	NULL
inducible	NULL
upon	NULL
culture	NULL
with	NULL
IL-2	NULL
that	NULL
can	NULL
be	NULL
further	NULL
enhanced	NULL
when	NULL
IL-2	NULL
is	NULL
combined	NULL
with	NULL
y-interferon	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
underlying	NULL
molecular	NULL
mechanism	NULL
,	NULL
including	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
mediating	NULL
this	NULL
Received	NULL
1/22/92	NULL
.	NULL
'	NULL

This	NULL
investigation	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Dr.	NULL
Mildred	NULL
Scheel	NULL
Stiftung	NULL
(	NULL
to	NULL
M.	NULL
A	NULL
.	NULL

B.	NULL
and	NULL
F.	NULL
H.	NULL
)	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Department	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
Medical	NULL
Center	NULL
,	NULL
Hugstetter	NULL
Strasse	NULL
55	NULL
,	NULL
D-7800	NULL
Freiburg	NULL
,	NULL
Germany	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
-R	NULL
,	NULL
receptor	NULL
;	NULL
PBMO	NULL
,	NULL
peripheral	NULL
blood	NULL
monocyte	NULL
(	NULL
s	NULL
)	NULL
;	NULL
hGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
mt	NULL
,	NULL
mutant	NULL
;	NULL
kD	NULL
,	NULL
kilodalton	NULL
(	NULL
s	NULL
)	NULL
;	NULL
SSC	NULL
,	NULL
standard	NULL
saline	NULL
citrate	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
;	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
,	NULL
polyadenylated	NULL
.	NULL

induction	NULL
,	NULL
is	NULL
,	NULL
however	NULL
,	NULL
unknown	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
nuclear	NULL
basis	NULL
of	NULL
the	NULL
action	NULL
of	NULL
IL-2	NULL
on	NULL
IL-2R	NULL
a	NULL
chain	NULL
expression	NULL
.	NULL

Results	NULL
Treatment	NULL
of	NULL
human	NULL
PBMO	NULL
is	NULL
associated	NULL
with	NULL
IL-2R	NULL
a	NULL
chain	NULL
expression	NULL
by	NULL
these	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Whereas	NULL
resting	NULL
monocytes	NULL
did	NULL
not	NULL
display	NULL
transcripts	NULL
for	NULL
the	NULL
a	NULL
chain	NULL
of	NULL
the	NULL
IL-2R	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
treatment	NULL
with	NULL
IL-2	NULL
was	NULL
associated	NULL
with	NULL
accumulation	NULL
of	NULL
IL-2R	NULL
a	NULL
chain	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
IL-2	NULL
on	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
gene	NULL
,	NULL
nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
Northern	NULL
blot	NULL
data	NULL
,	NULL
resting	NULL
monocytes	NULL
constitutively	NULL
transcribed	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
PBMO	NULL
with	NULL
IL-2	NULL
results	NULL
in	NULL
strong	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
enhanced	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
is	NULL
at	NULL
least	NULL
in	NULL
part	NULL
due	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
by	NULL
IL-2	NULL
in	NULL
PBMO	NULL
.	NULL

The	NULL
next	NULL
set	NULL
of	NULL
experiments	NULL
was	NULL
designed	NULL
to	NULL
study	NULL
the	NULL
molecular	NULL
mechanism	NULL
mediating	NULL
this	NULL
transcriptional	NULL
activation	NULL
.	NULL

Deleted	NULL
forms	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
were	NULL
constructed	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
hGH	NULL
as	NULL
a	NULL
reporter	NULL
,	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
transfected	NULL
with	NULL
the	NULL
p	NULL
(	NULL
-317	NULL
)	NULL
IL-2R	NULL
a	NULL
promoter	NULL
fragment	NULL
responded	NULL
to	NULL
IL-2	NULL
with	NULL
an	NULL
approximately	NULL
8-fold	NULL
increase	NULL
in	NULL
hGH	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
whereas	NULL
monocytes	NULL
transfected	NULL
with	NULL
the	NULL
p	NULL
(	NULL
-225	NULL
)	NULL
IL-2R	NULL
a	NULL
promoter	NULL
fragment	NULL
failed	NULL
to	NULL
synthesize	NULL
hGH	NULL
upon	NULL
IL-2	NULL
treat-ment	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
various	NULL
other	NULL
deleted	NULL
promoter	NULL
constructs	NULL
[	NULL
p	NULL
(	NULL
-179	NULL
)	NULL
,	NULL
p	NULL
(	NULL
-141	NULL
)	NULL
,	NULL
p	NULL
(	NULL
-50	NULL
)	NULL
]	NULL
also	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
IL-2	NULL
with	NULL
enhanced	NULL
hGH	NULL
release	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
an	NULL
IL-2-responsive	NULL
element	NULL
located	NULL
between	NULL
positions	NULL
-317	NULL
and	NULL
-225	NULL
is	NULL
responsible	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
PBMO	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
an	NULL
enhancer	NULL
element	NULL
located	NULL
at	NULL
position	NULL
-291	NULL
to	NULL
-245	NULL
is	NULL
crucial	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
element	NULL
was	NULL
subcloned	NULL
in	NULL
front	NULL
of	NULL
the	NULL
heterologous	NULL
herpes	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
as	NULL
a	NULL
reporter	NULL
.	NULL

This	NULL
con-struct	NULL
,	NULL
termed	NULL
p	NULL
(	NULL
IL-R	NULL
a	NULL
)	NULL
TKGH	NULL
,	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
human	NULL
monocytes	NULL
,	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
U	NULL
937	NULL
,	NULL
and	NULL
resting	NULL
human	NULL
T-cells	NULL
.	NULL

This	NULL
IL-2R	NULL
a	NULL
chain	NULL
construct	NULL
responded	NULL
to	NULL
IL-2	NULL
in	NULL
monocytes	NULL
and	NULL
U	NULL
937	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T-cells	NULL
,	NULL
with	NULL
an	NULL
approximately	NULL
20-fold	NULL
enhancement	NULL
of	NULL
hGH	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
this	NULL
enhancer	NULL
p	NULL
{	NULL
IL-2R	NULL
a	NULL
mt	NULL
)	NULL
TKGH	NULL
or	NULL
a	NULL
control	NULL
plasmid	NULL
without	NULL
this	NULL
enhancer	NULL
region	NULL
(	NULL
pTKGH	NULL
)	NULL
failed	NULL
to	NULL
display	NULL
enhanced	NULL
hGH	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
in	NULL
cultures	NULL
of	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
this	NULL
region	NULL
contains	NULL
an	NULL
IL-2-responsive	NULL
element	NULL
which	NULL
is	NULL
functional	NULL
in	NULL
monocytic	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
T-cells	NULL
.	NULL

422	NULL
-	NULL
Interleukin	NULL
2	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Medium	NULL
IL	NULL
-	NULL
2	NULL
actin	NULL
-	NULL
,	NULL
Fol	NULL
%	NULL
»	NULL
vector	NULL
--	NULL
IL-2R	NULL
a	NULL
_	NULL
-	NULL
@	NULL
r	NULL
Fig	NULL
.	NULL

1.	NULL
.	NULL

Effect	NULL
of	NULL
IL-2	NULL
(	NULL
100	NULL
units/ml	NULL
;	NULL
4	NULL
h	NULL
)	NULL
on	NULL
the	NULL
transcriptional	NULL
rate	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
chain	NULL
gene	NULL
in	NULL
PBMO	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
IL-2	NULL
)	NULL
or	NULL
absence	NULL
{	NULL
medium	NULL
)	NULL
of	NULL
IL-2	NULL
.	NULL

In	NULL
vitro	NULL
transcribed	NULL
,	NULL
labeled	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
IL-2R	NULL
«	NULL
chain	NULL
gene	NULL
(	NULL
/L-2R	NULL
a	NULL
)	NULL
,	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
to	NULL
vector	NULL
DNA	NULL
(	NULL
vector	NULL
)	NULL
,	NULL
and	NULL
as	NULL
internal	NULL
standardization	NULL
to	NULL
the	NULL
actin	NULL
gene	NULL
{	NULL
actin	NULL
}	NULL
.	NULL

EMSA	NULL
assays	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
whether	NULL
IL-2-induced	NULL
nuclear	NULL
factors	NULL
could	NULL
bind	NULL
to	NULL
a	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
this	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
nuclear	NULL
proteins	NULL
from	NULL
resting	NULL
monocytes	NULL
displayed	NULL
a	NULL
faint	NULL
retarded	NULL
band	NULL
when	NULL
incubated	NULL
with	NULL
this	NULL
fragment	NULL
.	NULL

Complex	NULL
formation	NULL
was	NULL
enhanced	NULL
when	NULL
nuclear	NULL
proteins	NULL
from	NULL
monocytes	NULL
exposed	NULL
to	NULL
IL-2	NULL
for	NULL
15	NULL
min	NULL
were	NULL
analyzed	NULL
.	NULL

Binding	NULL
activity	NULL
of	NULL
this	NULL
factor	NULL
peaked	NULL
after	NULL
30	NULL
to	NULL
60	NULL
min	NULL
and	NULL
returned	NULL
to	NULL
baseline	NULL
levels	NULL
within	NULL
2	NULL
h	NULL
upon	NULL
exposure	NULL
to	NULL
IL-2	NULL
.	NULL

Comparable	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U	NULL
937	NULL
was	NULL
analyzed	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
whereas	NULL
resting	NULL
T-cells	NULL
displayed	NULL
high	NULL
constitutive	NULL
binding	NULL
of	NULL
this	NULL
factor	NULL
as	NULL
compared	NULL
to	NULL
resting	NULL
monocytes	NULL
,	NULL
which	NULL
were	NULL
,	NULL
however	NULL
,	NULL
only	NULL
weakly	NULL
,	NULL
if	NULL
at	NULL
all	NULL
,	NULL
able	NULL
to	NULL
be	NULL
enhanced	NULL
by	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
IL-2-mediated	NULL
induction	NULL
of	NULL
complex	NULL
formation	NULL
by	NULL
monocytes	NULL
was	NULL
dose	NULL
dependent	NULL
and	NULL
detectable	NULL
in	NULL
the	NULL
range	NULL
of	NULL
100	NULL
to	NULL
1000	NULL
units/ml	NULL
of	NULL
IL-2	NULL
.	NULL

No	NULL
significant	NULL
dose	NULL
dependency	NULL
was	NULL
observed	NULL
below	NULL
100	NULL
units/ml	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
IL-2	NULL
for	NULL
1	NULL
h	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
IL-2-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
region	NULL
(	NULL
position	NULL
-291	NULL
to	NULL
-245	NULL
)	NULL
contains	NULL
a	NULL
recognition	NULL
site	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
with	NULL
a	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
«	NULL
B	NULL
immunoglobulin	NULL
gene	NULL
were	NULL
able	NULL
to	NULL
completely	NULL
inhibit	NULL
binding	NULL
of	NULL
monocyte-	NULL
and	NULL
T-cell-derived	NULL
nuclear	NULL
proteins	NULL
,	NULL
whereas	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
competition	NULL
assay	NULL
also	NULL
revealed	NULL
that	NULL
monocyte-	NULL
and	NULL
T-cell-derived	NULL
nuclear	NULL
proteins	NULL
gave	NULL
different	NULL
patterns	NULL
of	NULL
retarded	NULL
bands	NULL
,	NULL
indicating	NULL
size	NULL
heter-ogeneities	NULL
of	NULL
the	NULL
proteins	NULL
involved	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
molecular	NULL
size	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
proteins	NULL
was	NULL
analyzed	NULL
by	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
T-cell-derived	NULL
proteins	NULL
appeared	NULL
to	NULL
be	NULL
50	NULL
,	NULL
75	NULL
,	NULL
and	NULL
85	NULL
kD	NULL
in	NULL
size	NULL
,	NULL
whereas	NULL
monocyte-derived	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
was	NULL
only	NULL
50	NULL
kD	NULL
in	NULL
size	NULL
.	NULL

In	NULL
additional	NULL
experiments	NULL
,	NULL
EMSA	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
untreated	NULL
and	NULL
IL-2-exposed	NULL
monocytes	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
purified	NULL
from	NULL
human	NULL
placenta	NULL
.	NULL

Purified	NULL
p50	NULL
protein	NULL
comigrated	NULL
with	NULL
the	NULL
IL-2-inducible	NULL
monocyte-derived	NULL
nuclear	NULL
factor	NULL
.	NULL

In	NULL
additional	NULL
experiments	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
IL-2	NULL
on	NULL
mRNA	NULL
accumulation	NULL
of	NULL
the	NULL
p50	NULL
gene	NULL
coding	NULL
for	NULL
one	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
the	NULL
p65	NULL
gene	NULL
coding	NULL
for	NULL
the	NULL
IkB	NULL
receptor-binding	NULL
subunit	NULL
were	NULL
investigated	NULL
(	NULL
8	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
resting	NULL
monocytes	NULL
failed	NULL
to	NULL
display	NULL
p50	NULL
mRNA	NULL
on	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cytoplasmic	NULL
RNA	NULL
.	NULL

When	NULL
,	NULL
however	NULL
,	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
selected	NULL
RNA	NULL
was	NULL
used	NULL
,	NULL
a	NULL
faint	NULL
signal	NULL
for	NULL
p50	NULL
and	NULL
p65	NULL
became	NULL
detectable	NULL
in	NULL
resting	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
IL-2	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
the	NULL
3.9-kilobase	NULL
p50	NULL
mRNA	NULL
levels	NULL
at	NULL
12	NULL
h.	NULL
Maximal	NULL
levels	NULL
were	NULL
achieved	NULL
by	NULL
24	NULL
h	NULL
,	NULL
whereas	NULL
longer	NULL
duration	NULL
of	NULL
IL-2	NULL
exposure	NULL
(	NULL
48	NULL
h	NULL
)	NULL
caused	NULL
down-regulation	NULL
of	NULL
p50	NULL
transcript	NULL
levels	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
IL-2	NULL
did	NULL
not	NULL
alter	NULL
transcript	NULL
levels	NULL
of	NULL
the	NULL
p65	NULL
gene	NULL
during	NULL
this	NULL
time	NULL
course	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
NF-kB	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
following	NULL
activation	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
active	NULL
phorbol	NULL
esters	NULL
,	NULL
the	NULL
tax	NULL
protein	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
1	NULL
,	NULL
double	NULL
stranded	NULL
RNA	NULL
,	NULL
interleukin	NULL
1	NULL
,	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
IL-2	NULL
also	NULL
has	NULL
to	NULL
be	NULL
considered	NULL
as	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
NF-xB	NULL
binding	NULL
activity	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
B	NULL
chain	NULL
by	NULL
monocytes	NULL
is	NULL
sufficient	NULL
to	NULL
allow	NULL
IL-2	NULL
to	NULL
dissociate	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
its	NULL
cytoplasmic	NULL
inhibitor	NULL
and	NULL
generate	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
its	NULL
consensus	NULL
sequence	NULL
within	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
.	NULL

Enhanced	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
its	NULL
recognition	NULL
site	NULL
translates	NULL
into	NULL
functional	NULL
activation	NULL
,	NULL
in	NULL
that	NULL
a	NULL
heterologous	NULL
promoter	NULL
containing	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
enhancer	NULL
element	NULL
is	NULL
transcriptionally	NULL
activated	NULL
upon	NULL
IL-2	NULL
treatment	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
whereas	NULL
resting	NULL
T-cells	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
with	NULL
enhanced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
or	NULL
functional	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
monocyte	NULL
and	NULL
T-cell-derived	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
(	NULL
-291	NULL
to	NULL
-245	NULL
)	NULL
differ	NULL
not	NULL
only	NULL
in	NULL
their	NULL
inducibility	NULL
by	NULL
IL-2	NULL
,	NULL
but	NULL
also	NULL
in	NULL
their	NULL
molecular	NULL
size	NULL
.	NULL

This	NULL
observation	NULL
might	NULL
indicate	NULL
that	NULL
cell	NULL
type-specific	NULL
expression	NULL
of	NULL
distinct	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
mediates	NULL
signal-dependent	NULL
induction	NULL
of	NULL
this	NULL
molecule	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
recent	NULL
work	NULL
is	NULL
of	NULL
note	NULL
demonstrating	NULL
that	NULL
inducible	NULL
activities	NULL
of	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
are	NULL
controlled	NULL
by	NULL
distinct	NULL
mechanisms	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Monocytes	NULL
respond	NULL
to	NULL
IL-2	NULL
by	NULL
releasing	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
and	NULL
increased	NULL
cytotoxicity	NULL
(	NULL
13	NULL
)	NULL
.	NULL

IL-2	NULL
was	NULL
further	NULL
found	NULL
to	NULL
induce	NULL
monocytes	NULL
to	NULL
express	NULL
several	NULL
protooncogenes	NULL
,	NULL
including	NULL
c-fos	NULL
,	NULL
c-myc	NULL
,	NULL
c-pim	NULL
,	NULL
and	NULL
c-fms	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
signal	NULL
transduction	NULL
pathway	NULL
following	NULL
binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
surface	NULL
binding	NULL
sites	NULL
,	NULL
however	NULL
,	NULL
is	NULL
presently	NULL
unknown	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
indicated	NULL
that	NULL
common	NULL
signal	NULL
transduction	NULL
pathways	NULL
such	NULL
as	NULL
protein	NULL
kinase	NULL
C	NULL
translocation	NULL
,	NULL
calcium	NULL
mobilization	NULL
,	NULL
and	NULL
phosphatidylinositol	NULL
turnover	NULL
are	NULL
not	NULL
directly	NULL
involved	NULL
in	NULL
IL-2	NULL
signal	NULL
transduction	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
,	NULL
now	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
show	NULL
that	NULL
IL-2	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
molecule	NULL
NF-xB	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
functional	NULL
high	NULL
affinity	NULL
IL-2R	NULL
,	NULL
and	NULL
that	NULL
exposure	NULL
of	NULL
monocytes	NULL
to	NULL
IL-2	NULL
also	NULL
leads	NULL
to	NULL
accumulation	NULL
of	NULL
transcripts	NULL
of	NULL
the	NULL
p50	NULL
gene	NULL
coding	NULL
for	NULL
a	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Transient	NULL
increase	NULL
of	NULL
p50	NULL
transcripts	NULL
,	NULL
however	NULL
,	NULL
occurred	NULL
after	NULL
evidence	NULL
for	NULL
enhanced	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
423	NULL
~317	NULL
hGH	NULL
+225	NULL
hGH	NULL
~317	NULL
-179	NULL
+141	NULL
-50	NULL
+1	NULL
GATCCGCTTGCTCSACCCTACCTTCAACGGCAGGGGAATCTCCCCTCTCCTCCFrTTATGG	NULL
NF-	NULL
xB	NULL
B	NULL
10°	NULL
10°	NULL
.	NULL

_	NULL
W	NULL
Medium	NULL
E	NULL
rg	NULL
'	NULL
u	NULL
'	NULL
“	NULL
2	NULL
o	NULL
2	NULL
o	NULL
a	NULL
w	NULL
10	NULL
\t	NULL
5	NULL
E	NULL
€	NULL
ao	NULL
I	NULL
G	NULL
£	NULL
(	NULL
-317	NULL
-225	NULL
Mo	NULL
Tig	NULL
.	NULL

2	NULL
.	NULL

+317	NULL
-225	NULL
U	NULL
937	NULL
A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
various	NULL
deleted	NULL
promoter	NULL
constructs	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
chain	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
(	NULL
hGH	NULL
)	NULL
as	NULL
a	NULL
reporter	NULL
.	NULL

Black	NULL
box	NULL
,	NULL
the	NULL
IL-2R	NULL
«	NULL
chain	NULL
promoter	NULL
enhancer	NULL
element	NULL
from	NULL
position	NULL
-291	NULL
to	NULL
position	NULL
-245	NULL
;	NULL
below	NULL
,	NULL
sequence	NULL
with	NULL
the	NULL
NF-xB	NULL
recognition	NULL
site	NULL
underlined	NULL
.	NULL

B	NULL
,	NULL
hGH	NULL
synthesis	NULL
of	NULL
monocytes	NULL
transfected	NULL
with	NULL
p	NULL
(	NULL
-317	NULL
)	NULL
IL-2R	NULL
«	NULL
(	NULL
-317	NULL
)	NULL
or	NULL
with	NULL
p	NULL
(	NULL
-221	NULL
)	NULL
IL-2R	NULL
a	NULL
(	NULL
-225	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
open	NULL
columns	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
closed	NULL
columns	NULL
}	NULL
of	NULL
IL-2	NULL
.	NULL

10°	NULL
Fi	NULL
|	NULL
}	NULL
f	NULL
1	NULL
=	NULL
10	NULL
1	NULL
,	NULL
€	NULL
95	NULL
}	NULL
&	NULL
;	NULL
ﬁ	NULL
&	NULL
«	NULL
b	NULL
T	NULL
{	NULL
'	NULL
0	NULL
\	NULL
€	NULL
10	NULL
)	NULL
q	NULL
F	NULL
i	NULL
l	NULL
1	NULL
i	NULL
1	NULL
1	NULL
T	NULL
|	NULL
10°	NULL
++	NULL
--	NULL
«	NULL
--	NULL
Mo	NULL
U	NULL
937	NULL
T	NULL
Mo	NULL
Transfection	NULL
with	NULL
p	NULL
(	NULL
IL-2R	NULL
alpha	NULL
)	NULL
TKGH	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

|	NULL
H	NULL
I	NULL
U	NULL
937	NULL
T	NULL
p	NULL
(	NULL
IL-28	NULL
alpha	NULL
.	NULL

mt	NULL
)	NULL
TKGH	NULL
c	NULL
oon	NULL
a	NULL
E	NULL
;	NULL
LM	NULL
OR	NULL
A	NULL
Mo	NULL
U	NULL
937	NULL
T	NULL
pTKGH	NULL
IL-2	NULL
induces	NULL
activity	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
.	NULL

Monocytes	NULL
(	NULL
Mo	NULL
)	NULL
,	NULL
U	NULL
937	NULL
cells	NULL
,	NULL
and	NULL
T-cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
heterologous	NULL
promoter	NULL
construct	NULL
containing	NULL
the	NULL
wild-type	NULL
[	NULL
f	NULL
(	NULL
-267/-244	NULL
)	NULL
;	NULL
p	NULL
{	NULL
IL-2R	NULL
a	NULL
)	NULL
TKGH	NULL
]	NULL
or	NULL
a	NULL
mutant	NULL
[	NULL
f	NULL
(	NULL
-267/-244	NULL
)	NULL
,	NULL
p	NULL
{	NULL
IL-2R	NULL
a	NULL
,	NULL
mt	NULL
)	NULL
TKGH	NULL
]	NULL
,	NULL
or	NULL
no	NULL
fragment	NULL
(	NULL
pTKGH	NULL
)	NULL
inserted	NULL
5	NULL
``	NULL
of	NULL
the	NULL
herpes	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
followed	NULL
by	NULL
the	NULL
hGH	NULL
gene	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
closed	NULL
columns	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
open	NULL
columns	NULL
)	NULL
of	NULL
IL-2	NULL
.	NULL

hGH	NULL
activity	NULL
in	NULL
culture	NULL
supernatants	NULL
was	NULL
assessed	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Four	NULL
additional	NULL
transfections	NULL
gave	NULL
comparable	NULL
results	NULL
,	NULL
For	NULL
protocol	NULL
,	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

424	NULL
Interleukin	NULL
2	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
>	NULL
]	NULL
:	NULL
|	NULL
60	NULL
minutes	NULL
C	NULL
ro	NULL
gop	NULL
s	NULL
$	NULL
g	NULL
5s	NULL
i	NULL
g	NULL
€	NULL
3	NULL
3	NULL
3	NULL
E	NULL
g	NULL
3	NULL
3	NULL
3	NULL
E	NULL
C	NULL
3	NULL
S	NULL
S	NULL
5	NULL
g	NULL
5	NULL
€	NULL
5	NULL
5	NULL
E	NULL
E	NULL
s	NULL
2	NULL
8	NULL
8	NULL
``	NULL
s	NULL
2	NULL
8	NULL
3g	NULL
``	NULL
f	NULL
.	NULL

'-..-'-	NULL
.	NULL

g	NULL
Wlvidh	NULL
Inuliatl	NULL
un	NULL
T	NULL
cells	NULL
Monocytes	NULL
U	NULL
937	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Medium	NULL
C	NULL
ro	NULL
mo	NULL
IL-2	NULL
(	NULL
U/m	NULL
!	NULL
)	NULL

10007	NULL
750	NULL
500	NULL
250	NULL
T	NULL
1	NULL
75	NULL
100	NULL
Percent	NULL
of	NULL
NFKB	NULL
Binding	NULL
25	NULL
50	NULL
A	NULL
,	NULL
time	NULL
course	NULL
for	NULL
IL-2	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
enhancer-binding	NULL
protein	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
prepared	NULL
from	NULL
blood	NULL
monocytes	NULL
,	NULL
monocytic	NULL
leukemia	NULL
line	NULL
U	NULL
937	NULL
,	NULL
or	NULL
T-cells	NULL
,	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
position	NULL
-291	NULL
to	NULL
-245	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

B	NULL
,	NULL
dose-dependent	NULL
effect	NULL
of	NULL
IL-2-induced	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
exposed	NULL
to	NULL
50	NULL
,	NULL
100	NULL
,	NULL
500	NULL
,	NULL
and	NULL
1000	NULL
units/ml	NULL
recombinant	NULL
human	NULL
IL-2	NULL
for	NULL
1	NULL
h.	NULL
Complex	NULL
formation	NULL
was	NULL
quantified	NULL
using	NULL
laser	NULL
densitometry	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
achieved	NULL
after	NULL
1	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
1000	NULL
units/ml	NULL
IL-2	NULL
was	NULL
set	NULL
as	NULL
100	NULL
%	NULL
.	NULL

2-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
,	NULL
suggesting	NULL
that	NULL
preexisting	NULL
protein	NULL
was	NULL
activated	NULL
by	NULL
IL-2	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
IL-2	NULL
is	NULL
effective	NULL
in	NULL
regulating	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
two	NULL
independent	NULL
mechanisms	NULL
at	NULL
two	NULL
levels	NULL
.	NULL

Alternatively	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
might	NULL
be	NULL
associated	NULL
with	NULL
autoinduction	NULL
of	NULL
the	NULL
p50	NULL
gene	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
clarify	NULL
whether	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
also	NULL
sufficient	NULL
to	NULL
mediate	NULL
other	NULL
effects	NULL
than	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
a	NULL
chain	NULL
or	NULL
whether	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
high	NULL
affinity	NULL
IL-2R	NULL
engaging	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
necessary	NULL
to	NULL
allow	NULL
the	NULL
initiation	NULL
of	NULL
other	NULL
effects	NULL
of	NULL
IL-2	NULL
by	NULL
human	NULL
blood	NULL
monocytes	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
(	NULL
19	NULL
)	NULL
is	NULL
of	NULL
note	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
a	NULL
chain	NULL
primarily	NULL
acts	NULL
in	NULL
order	NULL
to	NULL
facilitate	NULL
the	NULL
interaction	NULL
of	NULL
IL-2	NULL
with	NULL
the	NULL
B	NULL
chain	NULL
of	NULL
the	NULL
IL-2R	NULL
,	NULL
thereby	NULL
increasing	NULL
its	NULL
affinity	NULL
for	NULL
IL-2	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Separation	NULL
.	NULL

Leukocyte	NULL
preparations	NULL
were	NULL
obtained	NULL
from	NULL
buffy	NULL
coats	NULL
of	NULL
blood	NULL
donated	NULL
by	NULL
consenting	NULL
healthy	NULL
volunteers	NULL
through	NULL
the	NULL
courtesy	NULL
of	NULL
the	NULL
Blood	NULL
Bank	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
.	NULL

Monocytes	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
buffy	NULL
coats	NULL
were	NULL
diluted	NULL
with	NULL
minimum	NULL
essential	NULL
medium	NULL
(	NULL
Seromed	NULL
Biochrom	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
centrifuged	NULL
over	NULL
a	NULL
Ficoll-Hypaque	NULL
cushion	NULL
(	NULL
Seromed	NULL
Biochrom	NULL
)	NULL
.	NULL

In-terphase	NULL
cells	NULL
were	NULL
then	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
two	NULL
subsequent	NULL
rosetting	NULL
steps	NULL
with	NULL
aminoethylisothiouron-ium	NULL
bromide-treated	NULL
sheep	NULL
red	NULL
blood	NULL
cells	NULL
(	NULL
Flow	NULL
Labo-ratories	NULL
,	NULL
Meckenheim	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
depletion	NULL
of	NULL
T-lym-phocytes	NULL
,	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
two	NULL
adherent	NULL
steps	NULL
of	NULL
the	NULL
E-rosette-negative	NULL
cell	NULL
fraction	NULL
.	NULL

Monocytes	NULL
obtained	NULL
in	NULL
this	NULL
way	NULL
were	NULL
>	NULL
97	NULL
%	NULL
pure	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
a-naphthyl	NULL
acetate	NULL
esterase	NULL
staining	NULL
and	NULL
-	NULL
immunofluorescence	NULL
analysis	NULL
using	NULL
anti-CD14	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
.	NULL

Human	NULL
monocytic	NULL
leukemia	NULL
U	NULL
937	NULL
cells	NULL
{	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
T-lymphocytes	NULL
,	NULL
and	NULL
monocytes	NULL
,	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Seromed	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
425	NULL
B.	NULL
,	NULL
Mo	NULL
T	NULL
e-	NULL
__	NULL
200	NULL
*	NULL
*	NULL
--	NULL
97	NULL
-	NULL
69	NULL
&	NULL
tnt	NULL
__	NULL
45	NULL
-	NULL
30	NULL
bo	NULL
.	NULL

hig	NULL
.	NULL

5	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
with	NULL
nuclear	NULL
proteins	NULL
extracted	NULL
from	NULL
IL	NULL
-2	NULL
(	NULL
100	NULL
units/ml	NULL
;	NULL
1	NULL
h	NULL
}	NULL
-treated	NULL
monocytes	NULL
(	NULL
Mo	NULL
)	NULL
(	NULL
Lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
T-cells	NULL
(	NULL
Lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
25-fold	NULL
excess	NULL
of	NULL
a	NULL
synthetic	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
«	NULL
B	NULL
immunoglobulin	NULL
gene	NULL
(	NULL
Lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
or	NULL
containing	NULL
the	NULL
recognition	NULL
sequence	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
(	NULL
Lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

B	NULL
,	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
(	NULL
15	NULL
)	NULL
with	NULL
nuclear	NULL
proteins	NULL
derived	NULL
from	NULL
IL-2	NULL
(	NULL
1	NULL
h	NULL
)	NULL
-treated	NULL
T-cells	NULL
(	NULL
T	NULL
)	NULL
or	NULL
monocytes	NULL
(	NULL
Mo	NULL
)	NULL
.	NULL

A	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
NF	NULL
-	NULL
«	NULL
B	NULL
recognition	NULL
site	NULL
within	NULL
the	NULL
-291	NULL
to	NULL
-245	NULL
enhancer	NULL
element	NULL
of	NULL
the	NULL
IL-28	NULL
«	NULL
chain	NULL
promoter	NULL
{	NULL
100,000	NULL
cpm	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
20	NULL
ug	NULL
nuclear	NULL
extracts	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
(	NULL
254	NULL
nm	NULL
)	NULL
.	NULL

Protein	NULL
complexes	NULL
were	NULL
analyzed	NULL
on	NULL
12	NULL
%	NULL
polyacrylamide-SDS	NULL
gel	NULL
under	NULL
reducing	NULL
condi-tions	NULL
.	NULL

Markers	NULL
indicate	NULL
protein	NULL
complexes	NULL
that	NULL
are	NULL
50/55	NULL
,	NULL
75	NULL
,	NULL
and	NULL
85	NULL
kD	NULL
in	NULL
size	NULL
.	NULL

Biochrom	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
low	NULL
endotoxin	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hazelton	NULL
,	NULL
Vienna	NULL
,	NULL
UT	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
mm	NULL
i-glutamine	NULL
and	NULL
1	NULL
%	NULL
penicillin-streptomycin	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
at	NULL
37°C	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Cetus	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
10	NULL
to	NULL
500	NULL
units/ml	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Cells	NULL
were	NULL
also	NULL
treated	NULL
with	NULL
10	NULL
ug/ml	NULL
cycloheximide	NULL
(	NULL
Sigma	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Total	NULL
Cellular	NULL
RNA	NULL
,	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
and	NULL
Run-on	NULL
Assay	NULL
.	NULL

Medium	NULL
or	NULL
IL-2	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
-treated	NULL
IL-2	NULL
|	NULL
2	NULL
2	NULL
2	NULL
g	NULL
2	NULL
50	NULL
5	NULL
5	NULL
R	NULL
3	NULL
O	NULL
O	NULL
O	NULL
“	NULL
g	NULL
9	NULL
€	NULL
5	NULL
£2	NULL
as	NULL
0	NULL
<	NULL
``	NULL
@	NULL
$	NULL
t	NULL
NF-	NULL
«	NULL
B	NULL
-	NULL
#	NULL
Actin	NULL
-+	NULL
»	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
p50	NULL
mRNA	NULL
by	NULL
IL-2	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
units/ml	NULL
recombinant	NULL
human	NULL
IL-2	NULL
for	NULL
4	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
and	NULL
harvested	NULL
thereafter	NULL
.	NULL

Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
40	NULL
ug	NULL
,	NULL
RNA	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
p50	NULL
complementary	NULL
DNA	NULL
probe	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
.	NULL

Rehybridization	NULL
with	NULL
actin	NULL
controls	NULL
for	NULL
comparable	NULL
RNA	NULL
loading	NULL
in	NULL
single	NULL
lanes	NULL
.	NULL

monocytes	NULL
were	NULL
harvested	NULL
after	NULL
the	NULL
appropriate	NULL
culture	NULL
time	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
in	NULL
guanidine	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
extracted	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
acetate-EDTA-equilibrated	NULL
phenol	NULL
.	NULL

This	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
60°C	NULL
for	NULL
25	NULL
min	NULL
with	NULL
frequent	NULL
vortexing	NULL
.	NULL

The	NULL
aqueous	NULL
phase	NULL
was	NULL
recovered	NULL
after	NULL
centrifugation	NULL
and	NULL
extracted	NULL
once	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
phenol-chloroform	NULL
and	NULL
twice	NULL
with	NULL
chloroform	NULL
.	NULL

The	NULL
resulting	NULL
RNA	NULL
was	NULL
precipitated	NULL
overnight	NULL
at	NULL
-20°C	NULL
with	NULL
2.5	NULL
volumes	NULL
of	NULL
ethanol	NULL
.	NULL

The	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
(	NULL
40	NULL
ug	NULL
)	NULL
was	NULL
then	NULL
elec-trophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
20	NULL
mm	NULL
sodium	NULL
borate	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
3	NULL
%	NULL
formalde-hyde	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
in	NULL
10	NULL
%	NULL
SSC	NULL
{	NULL
1.5	NULL
m	NULL
sodium	NULL
chloride	NULL
and	NULL
150	NULL
mm	NULL
sodium	NULL
citrate	NULL
)	NULL
using	NULL
capillary	NULL
blotting	NULL
overnight	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
backed	NULL
and	NULL
prehybridized	NULL
at	NULL
65°C	NULL
in	NULL
7	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
%	NULL
Denhardt	NULL
's	NULL
(	NULL
1	NULL
%	NULL
Denhardt	NULL
's	NULL
=	NULL
0.2	NULL
%	NULL
Ficoll	NULL
,	NULL
0.2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
0.02	NULL
%	NULL
polyvinyl	NULL
pyrolidine	NULL
)	NULL
,	NULL
5x	NULL
SSC	NULL
,	NULL
and	NULL
20	NULL
mm	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
the	NULL
EcoRl	NULL
fragment	NULL
of	NULL
the	NULL
pSP65	NULL
IL-2R	NULL
a	NULL
chain	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
T.	NULL
Waldman	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
the	NULL
Not	NULL
!	NULL

fragment	NULL
of	NULL
pBKS-p50	NULL
{	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
Ghosh	NULL
,	NULL
Whitehead	NULL
Institute	NULL
,	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
or	NULL
the	NULL
HindIl/Xbal	NULL
fragment	NULL
of	NULL
pRe	NULL
CMV-p65	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Bauerle	NULL
,	NULL
Genzentrum	NULL
,	NULL
University	NULL
of	NULL
Munich	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
radiolabeled	NULL
by	NULL
random	NULL
priming	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
P	NULL
]	NULL
JCTP	NULL
(	NULL
>	NULL
6000	NULL
Ci/mmol	NULL
)	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
at	NULL
55°C	NULL
in	NULL
1	NULL
%	NULL
SDS-1	NULL
%	NULL
x	NULL
SSC	NULL
and	NULL
autoradiographed	NULL
with	NULL
Kodak	NULL
XAR	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Roch-ester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-70°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

For	NULL
nuclear	NULL
run-on	NULL
assays	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RSB	NULL
[	NULL
10	NULL
mm	NULL
Tris-HCL-5	NULL
mm	NULL
KCl-3	NULL
mm	NULL
MgCl	NULL
,	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
Sigma	NULL
)	NULL
]	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
phos-phate-buffered	NULL
saline	NULL
.	NULL

Nuclei	NULL
were	NULL
incubated	NULL
at	NULL
26°C	NULL
in	NULL
15	NULL
%	NULL
glycerol-70	NULL
mm	NULL
KCI-2.5	NULL
mm	NULL
MgCl	NULL
;	NULL
-10	NULL
mm	NULL
EDTA	NULL
,	NULL
4	NULL
mm	NULL
concentrations	NULL
each	NULL
of	NULL
ATP	NULL
,	NULL
CTP	NULL
,	NULL
and	NULL
GTP	NULL
,	NULL
2	NULL
mm	NULL
426	NULL
Interleukin	NULL
2	NULL
Activation	NULL
of	NULL
NF-kB	NULL
UTP	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
60	NULL
units/ml	NULL
RNasin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
LCi	NULL
of	NULL
[	NULL
P	NULL
]	NULL
JUTP	NULL
3000	NULL
Ci/mmol	NULL
(	NULL
Amersham	NULL
Buchler	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
digested	NULL
with	NULL
DNase	NULL
|	NULL
and	NULL
proteinase	NULL
K	NULL
,	NULL
extracted	NULL
once	NULL
with	NULL
trichloroacetic	NULL
acid	NULL
and	NULL
phenol-chloroform	NULL
,	NULL
and	NULL
precipitated	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
buffer	NULL
before	NULL
hybridization	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cpm/ml	NULL
of	NULL
hybridization	NULL
buffer	NULL
{	NULL
50	NULL
%	NULL
form-amide-2x	NULL
SSC-1x	NULL
%	NULL
SDS-5x	NULL
Denhardt	NULL
's	NULL
solution	NULL
[	NULL
1x	NULL
Denhardt	NULL
's	NULL
solution	NULL
=	NULL
0.2	NULL
%	NULL
Ficoll-0.02	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Fraction	NULL
V	NULL
;	NULL
Sigma	NULL
)	NULL
-0.02	NULL
%	NULL
polyvinyl	NULL
pyrolidone	NULL
]	NULL
-5	NULL
ug/ml	NULL
tRNA	NULL
}	NULL
.	NULL

Filters	NULL
contained	NULL
10	NULL
ug	NULL
each	NULL
of	NULL
linearized	NULL
plasmid	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
)	NULL
.	NULL

After	NULL
hybridization	NULL
at	NULL
42°C	NULL
for	NULL
3	NULL
days	NULL
,	NULL
filters	NULL
were	NULL
rinsed	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
at	NULL
55°C	NULL
,	NULL
2	NULL
%	NULL
SSC	NULL
containing	NULL
10	NULL
ug/ml	NULL
RNase	NULL
A	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
,	NULL
finally	NULL
,	NULL
0.5	NULL
%	NULL
SSC	NULL
at	NULL
55°C	NULL
for	NULL
30	NULL
min	NULL
each	NULL
time	NULL
,	NULL
and	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
films	NULL
for	NULL
10	NULL
days	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
untreated	NULL
and	NULL
IL-2-treated	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

A	NULL
double	NULL
stranded	NULL
oligonucle-otide	NULL
,	NULL
corresponding	NULL
to	NULL
position	NULL
-291	NULL
to	NULL
-245	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
(	NULL
6	NULL
)	NULL
,	NULL
was	NULL
synthesized	NULL
and	NULL
end	NULL
labeled	NULL
using	NULL
the	NULL
Klenow	NULL
large	NULL
fragment	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
and	NULL
labeled	NULL
DNA	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
25	NULL
mm	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
1.0	NULL
ug	NULL
polydeoxyinosinic-deoxycytidylic	NULL
acid	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
12	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
analyzed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
synthetic	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
«	NULL
B	NULL
immunoglobulin	NULL
gene	NULL
{	NULL
(	NULL
ACAAGGGACTTTCCGCT	NULL
)	NULL
or	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
(	NULL
GATCCCGCT-GAC	NULL
TCATG	NULL
)	NULL
was	NULL
added	NULL
prior	NULL
to	NULL
incubation	NULL
.	NULL

For	NULL
comi-gration	NULL
experiments	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
purified	NULL
from	NULL
human	NULL
placenta	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Bauerle	NULL
,	NULL
Genzentrum	NULL
,	NULL
University	NULL
of	NULL
Munich	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
end-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
.	NULL

Preparation	NULL
of	NULL
Promoter	NULL
Constructs	NULL
and	NULL
Transfection	NULL
Assays	NULL
.	NULL

The	NULL
-317/+100	NULL
HindlIll/Kpni	NULL
fragment	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
was	NULL
blunt	NULL
ended	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
Hincil	NULL
site	NULL
of	NULL
pOGH	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Deleted	NULL
forms	NULL
were	NULL
made	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
of	NULL
the	NULL
Hind\II	NULL
!	NULL

/Kpnl	NULL
IL-2R	NULL
«	NULL
chain	NULL
promoter	NULL
fragment	NULL
as	NULL
follows	NULL
:	NULL
Xmnl	NULL
yielding	NULL
the	NULL
p	NULL
(	NULL
-225	NULL
)	NULL
fragment	NULL
,	NULL
Mnil	NULL
,	NULL
yielding	NULL
p	NULL
(	NULL
-179	NULL
)	NULL
,	NULL
EcoRI	NULL
,	NULL
yielding	NULL
p	NULL
(	NULL
-141	NULL
)	NULL
,	NULL
and	NULL
EcoRIl	NULL
,	NULL
yielding	NULL
p	NULL
(	NULL
-50	NULL
)	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
fragments	NULL
.	NULL

The	NULL
fragments	NULL
were	NULL
blunt	NULL
ended	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
Hincll	NULL
site	NULL
of	NULL
pOGH	NULL
.	NULL

A	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
-291	NULL
to	NULL
-245	NULL
fragment	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
promoter	NULL
containing	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
-	NULL
recognition	NULL
-	NULL
sequence	NULL
(	NULL
GGGGAATCTCCC	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
(	NULL
GCTCAATCTCCC	NULL
;	NULL
mutated	NULL
bases	NULL
are	NULL
underlined	NULL
)	NULL
site	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
Hincll	NULL
site	NULL
of	NULL
the	NULL
pTKGH	NULL
vector	NULL
containing	NULL
the	NULL
heterologous	NULL
herpes	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
termed	NULL
p	NULL
(	NULL
IL-2R	NULL
a	NULL
)	NULL
TKGH	NULL
or	NULL
p	NULL
(	NULL
IL-2R	NULL
a	NULL
,	NULL
mt	NULL
)	NULL
TKGH	NULL
,	NULL
respectively	NULL
.	NULL

Monocytes	NULL
,	NULL
U	NULL
937	NULL
cells	NULL
,	NULL
and	NULL
T-cells	NULL
were	NULL
transiently	NULL
transfected	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
23	NULL
)	NULL
with	NULL
p	NULL
(	NULL
IL-2R	NULL
e	NULL
)	NULL
TKGH	NULL
,	NULL
p	NULL
(	NULL
IL-2R	NULL
a	NULL
,	NULL
mt	NULL
)	NULL
TKGH	NULL
,	NULL
or	NULL
the	NULL
control	NULL
plasmid	NULL
pTKGH	NULL
not	NULL
containing	NULL
the	NULL
enhancer	NULL
element	NULL
,	NULL
maintained	NULL
in	NULL
SCM	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
in	NULL
SCM	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
500	NULL
units/ml	NULL
)	NULL
.	NULL

A	NULL
B-galactosidase	NULL
expression	NULL
vector	NULL
(	NULL
24	NULL
)	NULL
was	NULL
cotransfected	NULL
to	NULL
monitor	NULL
transfection	NULL
efficiency	NULL
.	NULL

Human	NULL
growth	NULL
hormone	NULL
activity	NULL
was	NULL
assessed	NULL
in	NULL
cell-free	NULL
supernatants	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
Furogenetics	NULL
N.V.	NULL
,	NULL
Tessen-derio	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

UV	NULL
Cross-linking	NULL
.	NULL

UV	NULL
cross-linking	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
oligonucleotide	NULL
was	NULL
body	NULL
labeled	NULL
with	NULL
the	NULL
Klenow	NULL
large	NULL
fragment	NULL
polymerase	NULL
(	NULL
Boehringer-Mannheim	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
mm	NULL
dGTP	NULL
,	NULL
5	NULL
mm	NULL
dATP	NULL
(	NULL
Boehringer-Mann-heim	NULL
)	NULL
,	NULL
5	NULL
mm	NULL
5'-bromodeoxyuridine	NULL
triphosphate	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
dCTP	NULL
(	NULL
Amersham	NULL
Buchler	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
IL-2-treated	NULL
monocytes	NULL
and	NULL
T-lymphocytes	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
fmol	NULL
body-labeled	NULL
oligonucleotide	NULL
as	NULL
described	NULL
above	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
(	NULL
254	NULL
nm	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
under	NULL
reducing	NULL
conditions	NULL
on	NULL
a	NULL
12	NULL
%	NULL
SDS	NULL
gel	NULL
.	NULL

A	NULL
rainbow	NULL
marker	NULL
(	NULL
Amersham	NULL
Buchler	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Mori	NULL
,	NULL
H.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
A	NULL
restricted	NULL
cytoplasmic	NULL
region	NULL
of	NULL
IL-2	NULL
receptor	NULL
$	NULL
chain	NULL
is	NULL
essential	NULL
for	NULL
growth	NULL
and	NULL
signal	NULL
transduction	NULL
but	NULL
not	NULL
for	NULL
ligand	NULL
binding	NULL
and	NULL
internalization	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
:	NULL
837-845	NULL
,	NULL
1989	NULL
.	NULL

2	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Naoki	NULL
,	NULL
K.	NULL
,	NULL
Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Levin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
Interaction	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
with	NULL
the	NULL
src-family	NULL
kinase	NULL
p56	NULL
``	NULL
:	NULL
identification	NULL
of	NULL
novel	NULL
intermolecular	NULL
associ-ation	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
252	NULL
:	NULL
1523-1528	NULL
,	NULL
1991	NULL
.	NULL

3	NULL
.	NULL

Espinoza-Delgado	NULL
,	NULL
I.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Winkler-Pickett	NULL
,	NULL
R.	NULL
,	NULL
Sugamura	NULL
,	NULL
L.	NULL
,	NULL
Varesio	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
Expression	NULL
and	NULL
role	NULL
of	NULL
p75	NULL
interleukin-2	NULL
receptor	NULL
on	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
171	NULL
;	NULL
1821-1826	NULL
,	NULL
1990	NULL
.	NULL

4	NULL
.	NULL

Herrmann	NULL
,	NULL
F.	NULL
,	NULL
Cannistra	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Levine	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
Expression	NULL
of	NULL
interleukin-2	NULL
receptors	NULL
and	NULL
binding	NULL
of	NULL
IL-2	NULL
by	NULL
y-interferon-induced	NULL
human	NULL
leukemic	NULL
and	NULL
normal	NULL
monocytic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
162	NULL
;	NULL
1111-1116	NULL
,	NULL
1985	NULL
.	NULL

5	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Wolff	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Holbrock	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
trans-activator	NULL
gene	NULL
for	NULL
HTLV-1	NULL
.	NULL

Cell	NULL
,	NULL
49	NULL
:	NULL
47-56	NULL
,	NULL
1987	NULL
.	NULL

6	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
333	NULL
:	NULL
776-778	NULL
,	NULL
1988	NULL
.	NULL

7	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Leonardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
Functional	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
«	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
244	NULL
:	NULL
466-469	NULL
,	NULL
1989	NULL
.	NULL

8	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homol-ogy	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1019-1029	NULL
,	NULL
1990	NULL
.	NULL

9	NULL
.	NULL

Bduerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-xB	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
:	NULL
63-80	NULL
,	NULL
1991	NULL
.	NULL

10	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
10028-10035	NULL
,	NULL
1990	NULL
.	NULL

11	NULL
.	NULL

Herrmann	NULL
,	NULL
F.	NULL
,	NULL
Cannistra	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Lindemann	NULL
,	NULL
A.	NULL
,	NULL
Blohm	NULL
,	NULL
D.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
Functional	NULL
consequences	NULL
of	NULL
monocyte	NULL
IL-2	NULL
receptor	NULL
expression	NULL
:	NULL
induction	NULL
of	NULL
IL-1	NULL
8	NULL
secretion	NULL
by	NULL
IFN-y	NULL
and	NULL
IL-2	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
:	NULL
139-146	NULL
,	NULL
1989	NULL
.	NULL

12	NULL
.	NULL

Herrmann	NULL
,	NULL
F.	NULL
,	NULL
Gebauer	NULL
,	NULL
A.	NULL
,	NULL
Lindemann	NULL
,	NULL
A.	NULL
,	NULL
Brach	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
H.	NULL
Interleukin-2	NULL
and	NULL
interferon-y	NULL
recruit	NULL
different	NULL
subsets	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
to	NULL
secrete	NULL
interleukin-1	NULL
8	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
77	NULL
:	NULL
97-107	NULL
,	NULL
1989	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
427	NULL
13	NULL
.	NULL

Malkovsky	NULL
,	NULL
M.	NULL
,	NULL
Loveland	NULL
,	NULL
B.	NULL
,	NULL
North	NULL
,	NULL
M.	NULL
,	NULL
Asherson	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Gao	NULL
,	NULL
L.	NULL
,	NULL
Ward	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Fiers	NULL
,	NULL
W.	NULL
Recombinant	NULL
interleukin	NULL
2	NULL
directly	NULL
augments	NULL
the	NULL
cytotoxicity	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
324	NULL
:	NULL
262-265	NULL
,	NULL
1987	NULL
.	NULL

14	NULL
.	NULL

Espinoza-Delgado	NULL
,	NULL
I.	NULL
,	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Gusella	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Varesion	NULL
,	NULL
L.	NULL
Interleukin-2	NULL
enhances	NULL
c-fms	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
:	NULL
1137-1143	NULL
,	NULL
1990	NULL
.	NULL

15	NULL
.	NULL

Dautry	NULL
,	NULL
F.	NULL
,	NULL
Weil	NULL
,	NULL
D.	NULL
,	NULL
Yu	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dautry-Vasat	NULL
,	NULL
A	NULL
.	NULL

Regulation	NULL
of	NULL
pim	NULL
and	NULL
myb	NULL
mRNA	NULL
accumulation	NULL
by	NULL
interleukin-2	NULL
and	NULL
interleukin-3	NULL
in	NULL
murine	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
263	NULL
:	NULL
17615-17621	NULL
,	NULL
1988	NULL
.	NULL

16	NULL
.	NULL

Valge	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Wong	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Datlof	NULL
,	NULL
P.	NULL
,	NULL
Sinskey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
is	NULL
required	NULL
for	NULL
responses	NULL
to	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
but	NULL
not	NULL
to	NULL
interleukin-2	NULL
in	NULL
T-cells	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
101-111	NULL
,	NULL
1988	NULL
.	NULL

17	NULL
.	NULL

Le	NULL
Grue	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

Does	NULL
interleukin-2	NULL
stimulus-response	NULL
coupling	NULL
result	NULL
in	NULL
generation	NULL
of	NULL
intracellular	NULL
second	NULL
messenger	NULL
?	NULL

Lymphokine	NULL
Res	NULL
.	NULL

,	NULL
7	NULL
:	NULL
187-200	NULL
,	NULL
1988	NULL
.	NULL

18	NULL
.	NULL

Mills	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
Stewart	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Melfors	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Gelfland	NULL
,	NULL
E.	NULL
W.	NULL
Interleukin	NULL
2	NULL
does	NULL
not	NULL
induce	NULL
phosphatidylinositol	NULL
hydrolysis	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
136	NULL
;	NULL
3019-3024	NULL
,	NULL
1987	NULL
.	NULL

19	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
Kamio	NULL
,	NULL
M.	NULL
,	NULL
Okuma	NULL
,	NULL
M.	NULL
,	NULL
Ju	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Uchiyama	NULL
,	NULL
T.	NULL
The	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
alters	NULL
the	NULL
binding	NULL
of	NULL
IL-2	NULL
to	NULL
the	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
147	NULL
:	NULL
3396-3401	NULL
,	NULL
1991	NULL
.	NULL

20	NULL
.	NULL

Herrmann	NULL
,	NULL
F.	NULL
,	NULL
Oster	NULL
,	NULL
W.	NULL
,	NULL
Meuer	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Klein	NULL
,	NULL
K.	NULL
,	NULL
Lindemann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
H.	NULL
Interleukin-1	NULL
stimulates	NULL
T-lymphocytes	NULL
to	NULL
produce	NULL
GM-CSF	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
81	NULL
:	NULL
1415-1422	NULL
,	NULL
1988	NULL
.	NULL

21	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
6419	NULL
,	NULL
1989	NULL
.	NULL

22	NULL
.	NULL

Selden	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Howie	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Goodman	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
Human	NULL
growth	NULL
hormone	NULL
gene	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
regulation	NULL
studies	NULL
employing	NULL
transient	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
6	NULL
:	NULL
3173-3179	NULL
,	NULL
1986	NULL
.	NULL

23	NULL
.	NULL

Groschedl	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Cell-type	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
,	NULL
41	NULL
:	NULL
885-897	NULL
,	NULL
1985	NULL
.	NULL

24	NULL
.	NULL

Price	NULL
,	NULL
}	NULL
.	NULL

,	NULL
Turner	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Cepko	NULL
,	NULL
C.	NULL
Lineage	NULL
analysis	NULL
in	NULL
the	NULL
vertebrate	NULL
nervous	NULL
system	NULL
by	NULL
retrovirus-mediated	NULL
gene	NULL
transfer	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
:	NULL
156-160	NULL
,	NULL
1987	NULL
.	NULL

25	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Carthew	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

A	NULL
single	NULL
polypeptide	NULL
possesses	NULL
the	NULL
binding	NULL
and	NULL
transcription	NULL
activities	NULL
of	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
4723-4733	NULL
,	NULL
1986	NULL
.	NULL

